Home›People›Rifat Pamukcu
Rifat Pamukcu

Rifat Pamukcu

Chairperson of the Board at Corami Biotech. Also a director at BobcatBio.

DirectorPublic companyRoles at 2 startups
Updated Nov 10, 2026·Latest SEC filing Jun 17, 2026·Suggest an edit

About Rifat Pamukcu

Rifat Pamukcu is a chairperson of the board at Corami Biotech.

Form D filings also name Rifat Pamukcu as a director at BobcatBio.

Rifat Pamukcu reports to the SEC as a director of 1 public company: Aprea Therapeutics (APRE).

Rifat Pamukcu first appears on SEC filings in 2021.

Experience

This experience comes from Rifat Pamukcu's profile and from SEC filings. For roles taken from filings, the years are when the filings name Rifat Pamukcu in the role, so the role may have started earlier or lasted longer.

Corami Biotech Inc. Current
Chairperson of the Board
2024 – Present · Memphis, TN
Corami develops a heart-targeted drug delivery system for companies developing cardiovascular therapies.
Aprea Therapeutics, Inc. Current
Director Board of Directors
2022 – Present · Public company (APRE)
Sensa Neuroscience Current
Director Board of Directors
2022 – Present
RxMP Therapeutics Current
Director, President & Chief Executive Officer
2021 – Present
BobcatBio, Inc. Current
Director Board of Directors
2020 – Present · Hummelstown, PA
Syantra Inc. Current
Chairperson of the Board
2019 – Present
Lab2Market, PBC Current
Business Advisor - NIH & VA Biomedical Technology C3i Commercialization Program
2017 – Present
NephroDI Therapeutics, Inc. Current
Strategic Business & Clinical Consultant
2017 – Present
Biolocity Current
Oversight Commitee Member
2014 – Present
MidwayBiome Current
Founding Board Member
2003 – Present
Virion Therapeutics, LLC
Founding Board Member
2018 – 2025
Drexel University
Oversight Committee Member: Coulter-Drexel Translational Research Partnership Program
2009 – 2023
ATRIN PHARMACEUTICALS
Founding Board Member
2012 – 2022
The Wallace H. Coulter Foundation
Strategic Consultant
2008 – 2021
Thetis Pharmaceuticals
Strategic Advisor
2015 – 2019
BioComX C3i
Business Advisor - NIH & VA C3i Biomedical Technology Commercialization Program
2014 – 2017
Cell Pathways Inc.
Founder, Director, Chief Medical Officer, Chief Scientific Officer
1993 – 2003
University of Cincinnati School of Medicine
Assistant Professor of Medicine
1989 – 1993

Key Colleagues at Startups

The people Rifat Pamukcu works with at each company, as listed on that company's latest Form D.

Corami Biotech Inc. · Form D, Apr 22, 2026
Esra Roan
Esra Roan
Chief Executive Officer and director
Brian Walsh
Brian Walsh
Medical Technology Executive and director
NS
BobcatBio, Inc. · Form D, Mar 12, 2025
RS
TT
SR
Stephen Rocamboli
CEO and director

Sources

  1. SECCorami Biotech Inc. Form D, filed Apr 22, 2026
  2. SECBobcatBio, Inc. Form D, filed Mar 12, 2025
  3. SECForms 3, 4 and 5 filed by Rifat Pamukcu (SEC filer 1929298)